• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S201: TUBERCULUM SELLAE MENINGIOMAS: ANATOMICAL DETERMINANTS OF SURGICAL APPROACH
Silky Chotai, MD; Alan J Gordillo; Aritra Nag, MD; Erion De Andrade, MD; Pranay Soni, MD; Varun Kshettry, MD; Pablo Recinos, MD; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Introduction: Endoscopic endonasal (EEA) and transcranial (TCA) approaches for tuberculum sellae meningiomas (TSMs)  have advantages and limitations. This study aimed to identify anatomical factors influencing surgical approach selection.

Methods: TSM surgeries between 2014–2024 were reviewed, excluding tumors centered on the planum, extending to the olfactory groove, or multiple anterior skull base tumors. Preoperative MRI and CT sinus were reviewed for anatomical and tumor-specific features (Table). Univariable and multivariable analyses were performed.

Results: Total 82 patients were analyzed (EEA,n=43; TC,n=39). Most patients with ACA encasement (64% vs 30%, p=0.002) and those with extent of tumor >1mm lateral to the cisternal segment of the optic nerve underwent TCA (p<0.001). Tumors with larger maximum diameter (2.8±0.8 cm vs. 2.1±0.8 cm,p<0.001) and wider dural base at TS (25.2 ± 5.3 vs. 21.4 ± 5.6, p=0.002) underwent TCA. The optic canal invasion did not impact the approach selection. The patients with bilateral optic nerve compression were more likely to undergo TCA (84.6% vs. 48.8%). The rates of GTR (72.1% vs. 74.4%,p =0.508), preoperative visual deficits (81.6% vs. 77.5%,p=0.201), and postoperative improvement were similar (61.3% vs. 67.7%,p=0.435). Adjusting for ACA encasement, tumor size, extent of optic canal invasion, and widest dural base, the lateral tumor extent significantly influenced surgical approach selection (OR=2.63, p=0.019).

Conclusion: In a single-center study where there is equipoise in the approach selection for TSM, we demonstrate that the tumor extent >1 mm lateral to the cisternal segment of the optic nerve is a key determinant of approach selection. ACA encasement, larger tumors, and wider dural base also favored TCA. Both EEA and TCAs achieve comparable GTR and visual outcomes. 

  Endocopic (n=43) Transcranial (n=39) p-value
ACA encasement 13(30.2%) 25(64.1%) 0.002
 ICA encasement    6(14%)  7(17.9%)  0.423
 Optic canal invasion   42(97.7%)  38(97.4%)  0.728
 <3 mm  26 (61.9%)  26 (68.4%)  0.354
 >3 mm  16(38.1%)  12(31.6%)  
 Optic nerves       0.01
   Not involved  1(2.4%)  0  
   Unilateral compressed   13(31.7%)  0  
   Bilateral compressed    20(48.8%)   33(84.6%)  
   Abutting     5(12.2%)   1(2.6%)  
   Thinned    2(4.9%)   5(12.8%)  
   Interoptic distance    16.6±1.9   17.1±2.1  0.201
  Lateral extent of tumor      <0.001
   No   37(86%)   20(51.3%)  
   <1 mm   6(13.9%)   7(17.9%)  
   >1 mm   0   12(30.8%)  
  Pneumatization      0.078
  Pre-sellar   4(9.5%)   7(17.9%)  
  Sellar   10(23.8%)   13(33.3%)  
  Post-sellar   28(66.7%)   19(48.7%)  
  Angle of sella   107.8±9.2   110.7±12.2  0.241
  Widest dural base (mm)   21.4±5.6   25.2±5.3   0.002
 Tumor diameter (cm)   2.1±0.8   2.8±0.8   <0.001

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved